Clasado Biosciences (‘Clasado’), a global leader in the development of clinically proven prebiotic ingredient and product solutions for the human gut microbiome, has called on the health and nutrition sectors to encourage greater understanding of the gut microbiome’s role in supporting immune health.
Following the company’s recent multimedia programme detailing the complex interplay between the gut and the immune system, as well as the development and release of a brand-new whitepaper, Clasado has reiterated that key knowledge gaps exist in public understanding of this complex relationship. As a response, the business is reaffirming its commitment to accessible gut health learning.
Per Rehné, CEO of Clasado, commented: “There’s no doubt that public interest in immune health is peaking in light of the COVID-19 pandemic. Collectively, we’re all getting better acquainted with our immune system and how best to support it. A key area that we feel needs to be better understood and communicated is the influence the gut microbiome has on immune health. We intend to lead by example, taking every opportunity to discuss the science, and continuing to create free impartial learning resources for industry professionals.
“Since the beginning of the pandemic, we have seen leading scientists and medical professionals unite to urge the UK Government’s Health Secretary to hasten studies on the gut and immune system interplay, which indicates that there’s still much more to uncover. We know that around 70% of the immune system resides in the gut and so it shouldn’t come as a surprise that the gut and the body’s natural defences are closely linked. We have seen evidence of this relationship first-hand in the research and development of our prebiotic GOS ingredient, Bimuno®.”
Clasado notes that despite increasing consumer awareness of both immune health and gut health independently, the connection between the two is not broadly understood. The business cites exciting research projects across the sector as the next significant step-change in boosting public health awareness.
Rehné concluded: “The next steps are clear; we need to turn the wider role of gut health into common knowledge. We know the relationship between the gut and the immune system exists. How we communicate it, inspire the public, and use it to build tomorrow’s health and wellness solutions will be critical to maintaining a lot of the developmental momentum we’re seeing in the food and nutraceutical sectors today.”
To find out more about Clasado Biosciences, please visit www.clasado.com
###
For business to business marketing communications purposes only.
For further media enquiries, please contact Danny Graham at PHD Marketing Ltd.
Tel: +44 (0) 1977 708643
Email: danny.graham@
Notes to editors
Clasado is a leading biotechnology pioneer in the development of microbiome science producing prebiotic ingredients and consumer products aimed at gastrointestinal wellness destined for the food and healthcare sectors.
To find out more, please visit www.clasado.com
For more information on Clasado Biosciences and its activities, please contact PHD Marketing Ltd. The Cavalier Suite, The Barracks, Wakefield Road, Pontefract, West Yorkshire UK WF8 4HH.
Tel: +44 (0) 1977 708 643 or Email: [email protected].
